Next Article in Journal
Progesterone-Induced Sperm Release from the Oviduct Sperm Reservoir
Previous Article in Journal
Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease
Previous Article in Special Issue
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
 
 
Article

Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa

1
Department of Molecular Biomedicine, Centro de Investigaciones Biológicas Margarita Salas (CSIC), 28040 Madrid, Spain
2
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM-ISCIII), 28034 Madrid, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editors: Irene Cozar-Castellano and German Perdomo
Cells 2022, 11(10), 1621; https://doi.org/10.3390/cells11101621
Received: 7 March 2022 / Revised: 3 May 2022 / Accepted: 10 May 2022 / Published: 12 May 2022
(This article belongs to the Special Issue Insulin-Degrading Enzyme in Health and Disease)
Insulin-degrading enzyme (IDE) was named after its role as a proteolytic enzyme of insulin. However, recent findings suggest that IDE is a widely expressed, multitask protein, with both proteolytic and non-proteolytic functions. Here, we characterize the expression of IDE in the mammalian retina in both physiological and pathological conditions. We found that IDE was enriched in cone inner segments. IDE levels were downregulated in the dystrophic retina of several mouse models of retinitis pigmentosa carrying distinct mutations. In rd10 mice, a commonly studied mouse model of retinitis pigmentosa, treatment with an IDE activator (a synthetic peptide analog of preimplantation factor) delayed loss of visual function and preserved photoreceptor cells. Together, these results point to potential novel roles for IDE in retinal physiology and disease, further extending the list of diverse functions attributed to this enzyme. View Full-Text
Keywords: insulin-degrading enzyme; retinitis pigmentosa; retina; neurodegeneration; rd1; rd10; P23H; preimplantation factor insulin-degrading enzyme; retinitis pigmentosa; retina; neurodegeneration; rd1; rd10; P23H; preimplantation factor
Show Figures

Figure 1

MDPI and ACS Style

Sánchez-Cruz, A.; Hernández-Fuentes, M.D.; Murillo-Gómez, C.; de la Rosa, E.J.; Hernández-Sánchez, C. Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa. Cells 2022, 11, 1621. https://doi.org/10.3390/cells11101621

AMA Style

Sánchez-Cruz A, Hernández-Fuentes MD, Murillo-Gómez C, de la Rosa EJ, Hernández-Sánchez C. Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa. Cells. 2022; 11(10):1621. https://doi.org/10.3390/cells11101621

Chicago/Turabian Style

Sánchez-Cruz, Alonso, María D. Hernández-Fuentes, Cayetana Murillo-Gómez, Enrique J. de la Rosa, and Catalina Hernández-Sánchez. 2022. "Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa" Cells 11, no. 10: 1621. https://doi.org/10.3390/cells11101621

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop